leadf
logo-loader
viewFSD Pharma

Full interview: FSD Pharma rings the bell to open trading day on the Canadian Securities Exchange

FSD Pharma (CSE: HUGE-NASDAQ: HUGE) Executive Co-Chairman and CEO Dr Raza Bokhari joined Steve Darling from Proactive Vancouver to talk about the company ringing the bell to open the trading day on the CSE. 

Dr Bokhari also discussed their phase 1 first-in-human safety and tolerability trials for PP 101 micro-PEA 

Quick facts: FSD Pharma

Price: 2.33 CAD

CSE:HUGE
Market: CSE
Market Cap: $44.65 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end...

FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE.CN) (FRA:0K9A) CEO Raza Bokhari tells Proactive the group has submitted an Investigational New Drug (IND) application to the FDA for the use of its lead candidate FSD-201, or anti-inflammatory ultra-micronized-palmitoylethanolamide (PEA), to treat...

on 10/9/20

2 min read